Aaron Becker, MD
Urology · Jeffersonville, INNPI 1053575365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 412 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 52 manufacturers reported payments, led by Medtronic at 29.0% of the total.
Across 412 payments — averaging $34.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$907
- Procept Biorobotics Corporation$828
- Endo Pharmaceuticals Inc.$806
- Antares Pharma, Inc.$796
- Sumitomo Pharma America, Inc.$746
- plus $6K from 46 others
Across 2 payments — averaging $1184.27 each. An ownership or investment interest held by the physician or an immediate family member.
- Louisville URS Solutions, LLC$2K
What the payments were for
- Food & beverage$13,78298%
- Education$2902%
- Entertainment$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$2,489
- UroLift System$270
- ALTAVIVA$269
- JELMYTO$241
- AquaBeam Robotic System$237
- REZUM$210
- AMS 700$149
- 1788$144
- SPACEOAR VUE$138
- TITAN$137
- UroLift$132
- CellerateRx$127
- AQUABEAM SYSTEM$124
- GENERAL - THERAPIES$121
- CAMCEVI$107
- KEYTRUDA$106
- Prolaris$101
How this compares
$14,087 in reported general payments places this provider in the 80th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 163 | $105,469 |
| MyrbetriqMirabegron | 118 | $75,902 |
| XyostedTestosterone Enanthate | 18 | $10,824 |
| Tamsulosin Hcl | 1,092 | $9,736 |
| Testosterone | 30 | $6,196 |
| Trimethoprim | 107 | $5,385 |
| Testosterone Cypionate | 78 | $3,073 |
| Finasteride | 286 | $2,661 |
| Estradiol | 36 | $1,789 |
| Cephalexin | 227 | $1,138 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 120 | $1,135 |
| Silodosin | 24 | $961 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 67 | $951 |
| Oxybutynin Chloride | 11 | $375 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $746 | $105,469163 claims |
| Astellas Pharma US IncMyrbetriq | $476 | $75,902118 claims |
| Antares Pharma, Inc.Xyosted | $796 | $10,82418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 272 urology providers in Indiana.
Other urology in Jeffersonville
- James BailenJeffersonville$143K
- Greg SteinbockJeffersonville$134K
- Ryan MaloneJeffersonville$97K
- William SchmiedJeffersonville$58K
- Barry PechaJeffersonville$50K
- David RosenbaumJeffersonville$39K
- John EiflerJeffersonville$26K
- Ganesh RaoJeffersonville$19K
- Bradley BellJeffersonville$16K
- Dennis SmithJeffersonville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.